We commonly use metaphors to express our emotions and behaviors. “She has a heart of gold. He has cold feet. They’re on a rollercoaster of emotions.” Whether subtle or not, these words can have a powerful impact on our identity and relationships.
In the world of medicine, people frequently talk about “fighting cancer”, the “war on cancer”, or cells or the body being “invaded” or “attacked” by disease.
These warrior metaphors started gaining popularity in the 1940s and their use continues today. But why are they so widely used? Some believe these sentiments can help process difficult situations, and that portraying loved ones as heroes can feel empowering. Metaphors like these also acknowledge the physical challenges of the treatment process.1 But, warrior metaphors don’t always help.
When we use fighting terminology what are we accomplishing? How is a loved one with a cancer diagnosis considered a winner? If they succumb to their illness you hear it described as “losing the battle,” is it right to consider them a loser? These words cast a negative light on people with a cancer diagnosis, adding to the already tremendous hurdles that come with it.
What does it imply about people who become sick? Using warrior metaphors can stigmatize and victimize patients, or portray them as weak. They also falsely suggest that the patient has the power to control the results of their treatment.1 Paradoxically, this language can undermine the outlook of those undergoing cancer treatment.
Many clinicians rightly recommend using simple, direct language when discussing diagnosis and treatment instead of using language that can potentially do more harm than good. We must use language with more compassion for patients on their path to wellness. For all the right reasons, it’s time to make a conscious effort to shift away from the warrior metaphor.
Explore other resources!
Find other resources to help you and your loved ones throughout your journey.
Cited Sources
Waging War on War Metaphors in Cancer and COVID-19, Jonathan M. Marron, Don S. Dizon, Banu Symington, Michael A. Thompson, and Abby R. Rosenberg, JCO Oncology Practice 2020 16:10, 624-627